Royal Bank of Canada’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61K | Buy |
6,057
+3,391
| +127% | +$25.7K | ﹤0.01% | 5688 |
|
|
2026
Q1 | $19K | Sell |
2,666
-1,630
| -38% | -$10.5K | ﹤0.01% | 5923 |
|
|
2025
Q4 | $24K | Sell |
4,296
-373,944
| -99% | -$2.03M | ﹤0.01% | 5948 |
|
|
2025
Q3 | $2.33M | Sell |
378,240
-5,415
| -1% | -$31.7K | ﹤0.01% | 3270 |
|
|
2025
Q2 | $1.87M | Buy |
383,655
+382,301
| +28,235% | +$1.35M | ﹤0.01% | 3361 |
|
|
2025
Q1 | $5K | Buy |
1,354
+1,288
| +1,952% | +$5.51K | ﹤0.01% | 6369 |
|
|
2024
Q4 | $0 | Sell |
66
-2,132
| -97% | -$11.7K | ﹤0.01% | 7219 |
|
|
2024
Q3 | $15K | Sell |
2,198
-10,777
| -83% | -$87.4K | ﹤0.01% | 6214 |
|
|
2024
Q2 | $73K | Buy |
12,975
+12,909
| +19,559% | +$116K | ﹤0.01% | 5456 |
|
|
2024
Q1 | $1K | Sell |
66
-2,994
| -98% | -$28K | ﹤0.01% | 6857 |
|
|
2023
Q4 | $18K | Buy |
3,060
+512
| +20% | +$1.64K | ﹤0.01% | 6350 |
|
|
2023
Q3 | $6K | Buy |
2,548
+1,413
| +124% | +$5.48K | ﹤0.01% | 6585 |
|
|
2023
Q2 | $6K | Buy |
1,135
+881
| +347% | +$4.96K | ﹤0.01% | 6632 |
|
|
2023
Q1 | $1K | Sell |
254
-70
| -22% | -$421 | ﹤0.01% | 6929 |
|
|
2022
Q4 | $2K | Buy |
324
+85
| +36% | +$557 | ﹤0.01% | 6944 |
|
|
2022
Q3 | $1K | Buy |
239
+54
| +29% | +$545 | ﹤0.01% | 7262 |
|
|
2022
Q2 | $2K | Sell |
185
-226
| -55% | -$2.35K | ﹤0.01% | 6994 |
|
|
2022
Q1 | $7K | Sell |
411
-476
| -54% | -$8.4K | ﹤0.01% | 7125 |
|
|
2021
Q4 | $23K | Buy |
887
+292
| +49% | +$8.92K | ﹤0.01% | 6743 |
|
|
2021
Q3 | $21K | Sell |
595
-177
| -23% | -$7.52K | ﹤0.01% | 6686 |
|
|
2021
Q2 | $42K | Buy |
772
+147
| +24% | +$9.71K | ﹤0.01% | 6153 |
|
|
2021
Q1 | $52K | Sell |
625
-154
| -20% | -$17K | ﹤0.01% | 5855 |
|
|
2020
Q4 | $89K | Buy |
779
+146
| +23% | +$9.23K | ﹤0.01% | 5400 |
|
|
2020
Q3 | $19K | Sell |
633
-2
| -0.3% | -$77 | ﹤0.01% | 5721 |
|
|
2020
Q2 | $28K | Sell |
635
-8
| -1% | -$332 | ﹤0.01% | 5457 |
|
|
2020
Q1 | $23K | Buy |
643
+48
| +8% | +$2.38K | ﹤0.01% | 5480 |
|
|
2019
Q4 | $39K | Buy |
595
+557
| +1,466% | +$61.5K | ﹤0.01% | 5557 |
|
|
2019
Q3 | $6K | Buy |
+38
| New | +$4.3K | ﹤0.01% | 5973 |
|
|
2018
Q4 | – | Sell |
-20
| Closed | -$14K | – | 7076 |
|
|
2018
Q3 | $14K | Buy |
20
+14
| +233% | +$8.8K | ﹤0.01% | 5856 |
|
|
2018
Q2 | $3K | Buy |
6
+2
| +50% | +$615 | ﹤0.01% | 6181 |
|
|
2018
Q1 | $0 | Buy |
+4
| New | +$1.35K | ﹤0.01% | 6745 |
|
Other funds holding SLDB
RCM
PA
BCLSI
SL
AC
JT
Royal Bank of Canada's SLDB Position: Q2 2026 in Review
Royal Bank of Canada increased its Solid Biosciences (SLDB) stake by 127% in Q2 2026, buying an estimated $25.7K and bringing the position to 6,057 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #5688.
Royal Bank of Canada first reported a position in SLDB in Q1 2018 and has held it in 31 quarters since. The position peaked at $2.33M in Q3 2025. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.
- Royal Bank of Canada held 6,057 shares of Solid Biosciences worth $61K as of Q2 2026.
- Royal Bank of Canada bought 3,391 Solid Biosciences shares in Q2 2026, an estimated $25.7K.
- Solid Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #5688 holding.
- Royal Bank of Canada first reported a position in Solid Biosciences in Q1 2018 and has held it in 31 quarters since.
- Royal Bank of Canada's Solid Biosciences position peaked at $2.33M in Q3 2025.
- 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.